agilon health (NYSE:AGL) Trading Down 7.8% – Here’s What Happened

agilon health, inc. (NYSE:AGL) shares dropped 7.8% on Tuesday . The company traded as low as $2.02 and last traded at $2.02. Approximately 1,872,278 shares changed hands during trading, a decline of 61% from the average daily volume of 4,848,195 shares. The stock had previously closed at $2.19.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on the company. JMP Securities cut agilon health from an “outperform” rating to a “market perform” rating in a research report on Monday, November 11th. Barclays reduced their price target on agilon health from $5.00 to $2.00 and set an “underweight” rating on the stock in a report on Monday, November 11th. William Blair downgraded shares of agilon health from an “outperform” rating to a “market perform” rating in a research report on Friday, November 8th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $3.00 price target on shares of agilon health in a research note on Tuesday, November 19th. Finally, Citigroup reduced their price objective on shares of agilon health from $2.50 to $1.75 and set a “sell” rating on the stock in a research note on Wednesday, November 13th. Three analysts have rated the stock with a sell rating, sixteen have assigned a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $4.28.

agilon health Trading Down 3.6 %

The firm has a 50-day moving average price of $2.34 and a 200-day moving average price of $4.28. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06. The stock has a market capitalization of $774.59 million, a PE ratio of -2.00 and a beta of 0.51.

agilon health (NYSE:AGL) last released its earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). The company had revenue of $1.45 billion during the quarter, compared to analysts’ expectations of $1.47 billion. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. During the same quarter in the previous year, the firm earned ($0.06) earnings per share. As a group, equities analysts forecast that agilon health, inc. will post -0.52 EPS for the current fiscal year.

Insider Activity at agilon health

In other agilon health news, Director John William Wulf purchased 45,000 shares of the stock in a transaction on Thursday, December 5th. The shares were purchased at an average price of $2.18 per share, with a total value of $98,100.00. Following the acquisition, the director now directly owns 206,133 shares in the company, valued at approximately $449,369.94. The trade was a 27.93 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Karen Mcloughlin bought 25,000 shares of the business’s stock in a transaction that occurred on Friday, December 13th. The stock was bought at an average price of $2.20 per share, with a total value of $55,000.00. Following the completion of the transaction, the director now directly owns 73,166 shares of the company’s stock, valued at $160,965.20. This represents a 51.90 % increase in their position. The disclosure for this purchase can be found here. In the last ninety days, insiders acquired 90,000 shares of company stock worth $198,100. Corporate insiders own 3.20% of the company’s stock.

Institutional Investors Weigh In On agilon health

Institutional investors and hedge funds have recently bought and sold shares of the business. Point72 Asia Singapore Pte. Ltd. bought a new position in agilon health in the 3rd quarter worth $28,000. City State Bank purchased a new position in shares of agilon health during the 3rd quarter worth approximately $52,000. Nisa Investment Advisors LLC purchased a new position in shares of agilon health in the 2nd quarter valued at approximately $60,000. Allspring Global Investments Holdings LLC grew its stake in agilon health by 17,790.0% in the second quarter. Allspring Global Investments Holdings LLC now owns 10,734 shares of the company’s stock worth $70,000 after purchasing an additional 10,674 shares during the period. Finally, Signaturefd LLC grew its position in shares of agilon health by 166.2% in the 2nd quarter. Signaturefd LLC now owns 11,848 shares of the company’s stock worth $77,000 after buying an additional 7,398 shares during the period.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.